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We have analysed the intracellular localisation of herpes simplex virus type 1 ribonucleotide reductase during infection
of cultured cells by indirect immunofluorescence using polyclonal and monoclonal antibodies specific for the R1 and R2
subunits. Three different viruses were used to infect cells, wild-type strain 17/ and two temperature-sensitive mutants, ts
1222, which produces R1 only, and ts 1207, which expresses a normal R2 and an altered R1 that fails to interact with R2
at the nonpermissive temperature because of an amino acid substitution in R1. R1 was detected 2 hr postinfection with all
three viruses and remained evenly distributed throughout the cytoplasm. R2 was not observed until 4 hr postinfection and,
in contrast to the even distribution of R1, was localised in discrete cytoplasmic foci close to the nucleus. In double-labelling
experiments both R1 and R2 were found in these foci where they presumably associate to form the active enzyme. As
expected R2 was not detectable in cells infected with ts 1222. In ts 1207-infected cells it formed wild-type-like foci, indicating
that interaction with R1 is not required for R2 focus formation. R1 was present in a twofold excess over R2 in wild-type-
infected cells. We suggest that the uncomplexed R1 could perform a role associated with the protein kinase present in the
N-terminal domain. q 1995 Academic Press, Inc.
INTRODUCTION et al., 1994), varicella – zoster virus (Heineman and Co-
hen, 1994), and pseudorabies virus (de Wind et al., 1993).
The de novo synthesis of DNA in all living organisms
The C-terminal nonapeptide, YAGAVVNDL, of HSV R2 is
requires the conversion of ribonucleotides to the corre- a potent and specific inhibitor of HSV RR (Dutia et al.,
sponding deoxyribonucleotides, a reaction catalysed by 1986; Cohen et al., 1986), binding to R1 (Paradis et al.,
the enzyme ribonucleotide reductase (RR) (Reichard, 1988) and preventing its normal interaction with R2.
1993). A number of herpesviruses encode their own RR When targeted intracellularly YAGAVVNDL has an antivi-
(reviewed in Conner et al., 1994) and the active form of ral effect (Marcello et al., 1994) and peptidomimetic com-
the enzyme is a tetramer comprising homodimeric R1 pounds which inhibit virus replication in HSV-1-infected
and R2 subunits. For this class of RR the prototype is tissue cultured cells and in a murine ocular model of
the enzyme from Escherichia coli, and the 3-dimensional HSV-1-induced keratitis have been produced (Liuzzi et
structures of E. coli R1 and R2, but not the complex, have al., 1994).
been resolved (Nordlund et al., 1990; Uhlin and Eklund, The R1 subunit of HSV RR also possesses a protein
1994). The R1 subunit provides the active site which con- kinase (PK) activity (Chung et al., 1989; Paradis et al.,
tains redox-active thiols. Substrate reduction is depen- 1991; Conner et al., 1992a) that is distinct from conven-
dent on a tyrosyl radical, associated with a binuclear iron tional eukaryotic kinases (Conner et al., 1992a; Luo and
centre, in the R2 subunit. Subunit interaction is essential Aurelian, 1992; Cooper et al., 1995). This novel kinase
for activity and amino acids at the R2 C-terminus provide activity is located within the N-terminal 310 amino acids,
all the determinants required for R1 interaction (Dutia et a domain that is unique to HSV-1 and HSV-2 R1 subunits.
al., 1986; Cohen et al., 1986; Climent et al., 1991; Filatov The role of the R1 PK in HSV pathogenesis is not yet
et al., 1992). established.
Herpesvirus RR is essential for viral pathogenesis and We report here on the intracellular localisation of HSV
so is a target for antiviral chemotherapy. RR null mutants, R1 and R2 during infection of tissue culture cells and the
impaired for replication in tissue culture or in certain use of mutant viruses with alterations in one or the other
animal models of infection have been described for her- subunit to determine if the two subunits localise indepen-
pes simplex virus type 1 (HSV-1) (Preston et al., 1984; dently. Our results show a novel intracellular distribution
1988; Goldstein and Weller 1988a,b; Cameron et al., 1988; consistent with a role for R1 additional to that of reduction
Jacobson et al., 1989; Brandt et al., 1991; Ramakrishnan of ribonucleotides. A twofold excess of R1 over R2 was
found in virus-infected cells and, in contrast to the active
enzyme which localised to discrete cytoplasmic foci1 To whom reprint requests should be addressed at Department
around the nucleus, the uncomplexed R1 was evenlyof Biological Sciences, Glasgow Caledonian University, City Campus,
Cowcaddens Rd., Glasgow, GH OBA Scotland, UK. distributed throughout the cytoplasm.
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MATERIALS AND METHODS
Cells and viruses
BHK-21 clone 13 cells were infected with wild-type
HSV-1 strain 17/ or with HSV-1 temperature-sensitive
mutants ts 1222 and ts 1207. ts 1222 expresses R1 only,
as a single base pair deletion at the 3* end of the gene
specifying R2 alters the translational reading frame such
that all but 1 of the last 15 amino acids is unchanged
and the termination codon is removed (Preston et al.,
1988). ts 1207 expresses both R1 and R2 but a single
amino acid substitution at residue 961 of R1 prevents
subunit interaction at the nonpermissive temperature
(NPT) of 39.57 (Preston et al., 1984; Nikas et al., 1990).
The failure of ts 1207 and ts 1222 to produce an active
RR results in greatly reduced pathogenicity in mice (Cam-
eron et al., 1988). Infections were performed with 1– 5
FIG. 2. Mapping of regions recognised by MAbs 7602 and 7689.plaque forming units/cell.
Immunoprecipitated proteins were identified by Western blotting using
antiserum 106. Extracts containing intact R1 (lane 1), and polypeptidesAntibodies and epitope mapping
with 280 (lane 2), 348 (lane 3), 372 (lane 4), 420 (lane 5), 457 (lane
6), and 554 (lane 7) amino acids deleted from the N-terminus werePolyclonal antisera 33 and 106 were raised in rabbits
immunoprecipitated with (A) MAb 7602, (B) MAb 7689, or (C) controlusing purified HSV-1 R2 and dN245R1, a N-terminally trun- ascites. The extract used in lane 8 contained a N- and C-terminally
cated variant HSV-1 R1 that comprises amino acids 245– truncated polypeptide comprising R1 amino acids 247– 996.
1137 (Lankinen et al., 1991; Conner et al., 1993). Antipep-
tide antiserum 14995 was raised in rabbits against the
nonapeptide YAGAVVNDL (Dutia et al., 1986). Antiserum 1990) and these were mapped by immunoprecipitation
77 was produced by injection of rabbits with purified intact using the 31 different N- and C-terminally truncated R1
R1 (Furlong et al., 1991) using the protocol described in polypeptides (Conner et al., 1993). R1 proteins immunopre-
Conner et al. (1993) and was shown to be specific for R1 by cipitated by MAbs 7689 and 7602 were identified using
Western blotting (data not shown). Monoclonal antibodies Western blotting with antiserum 106. The regions of R1
(MAbs) 8578 and 8581 were produced as described pre- recognised by antisera 106 and 77 were identified in West-
viously (Marcello et al., 1994) and were specific for R2 ern blots using 10 b-galactosidase fusion proteins con-
as determined by immunoprecipitation (data not shown). taining fragments of R1 that span the entire protein (Lanki-
MAbs 7689 and 7602 recognise conformational epitopes nen et al., 1993). MAb Z1F11 recognises residues 360–
within the reductase domain of HSV-1 R1 (Nikas et al., 366 of UL42 (Murphy et al., 1989) and was used as a
control for nuclear localisation.
Indirect immunofluorescence
Infected or mock-infected cells were washed once
with phosphate-buffered saline containing 1% newborn
calf serum and fixed with ice-cold methanol for 10 min.
Cells were washed four times and incubated for 1 hr
with the first antibody at a dilution of 1:100. Prior to use
primary antibodies were preincubated overnight with a
confluent monolayer of BHK 21 cells to reduce nonspe-
cific background fluorescence. Cells were then washed
a further four times and incubated for 1 hr with second
antibody, either anti-rabbit or anti-mouse conjugated with
FITC or TRITC (Sigma). Cells were then washed three
times and coverslips were mounted on microscope
slides coated with Citifluor (UKC Chem Labs, Canterbury,
FIG. 1. Diagrammatic representation of HSV-1 R1 epitopes recog- UK). Immunolocalisation of R1 and R2 was observed by
nised by polyclonal and monoclonal antibodies used in immunolocali- fluorescence or confocal laser microscopy at 2, 4, 6, 8,sation. Black shading represents regions recognised by polyclonal anti-
and 12 hr after infection at 377. Immunolocalisation wasbodies and dotted regions identify the approximate location of mono-
clonal antibody epiptopes. also examined after 24 hr of infection at 317.
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FIG. 3. (A) Mock-infected cells probed with antisera 77 (i) or 33 (ii) (140 magnification). (B) HSV-1-infected cells probed with R1 polyclonal
antiserum 77 at 2 hr (i), 4 hr (ii), or 8 hr (iii) postinfection (140 magnification). (C) HSV-1-infected cells at 4 hr postinfection probed with F1 (i) or
MAb 7689 (ii) (160 magnification).
Quantitation of R1 and R2 in infected cells RESULTS
Epitope mapping of R1 antibodiesR1 and R2 in infected cells were quantified by limiting
dilution on Western blots using as standards known The locations of the epitopes recognised by the antibod-
ies used in this study are summarised in Fig. 1. Polyclonalamounts of purified proteins (Lankinen et al., 1991; Fur-
long et al., 1991) and using R1-specific antiserum 106 antiserum 77 recognised epitopes throughout the R1 pro-
tein while polyclonal antiserum 106 recognised epitopesand R2-specific antiserum 33. Infections with wild-type
virus were performed as described above and 2r5 1 throughout the conserved reductase domain as evidenced
by their reactivity in Western blots with the R1 fragment/b-105 cells were harvested directly with 100 ml of SDS –
polyacrylamide gel electrophoresis sample buffer at 2, galactosidase fusion proteins (Lankinen et al., 1993) span-
ning R1 (data not shown). The conformational epitopes of4, 6, and 8 hr postinfection.
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FIG. 4. (A) HSV-1-infected cells probed with either R2 polyclonal antiserum 33 at 2 hr (i), 4 hr (ii), or 6 hr (iii) or antipeptide antiserum 14995 at
4 hr (iv) postinfection (140 magnification). (B) HSV-1-infected cells at 4 hr postinfection probed with Z1F11 (140 magnification).
MAbs 7689 and 7602 were approximately located by immu- peptide was not immunoprecipitated by either MAb: we
suggest that deletion of R1 amino acids 349–372 affectsnoprecipitation (Fig. 2). Both MAbs reacted with full-length
R1 and polypeptides lacking 280 and 348 N-terminal amino the overall protein conformation such that it is no longer
recognised by these MAbs. Interestingly, this region of R1acids (Fig. 2, lanes 1–3). Neither MAb was able to immuno-
precipitate the polypeptide with 372 N-terminal residues between residues 349–373 is required for interaction with
R2 (Conner et al., 1993).deleted (Fig. 2, lane 4) nor polypeptides with more extensive
N-terminal deletions (Fig. 2, lanes 5–7). Interestingly, MAb
7689 but not MAb 7602 reacted with a N- and C-terminally Intracellular localisation of HSV-1 RR
deleted polypeptide comprising R1 amino acids 247–996
(Fig. 2, lane 8). MAb 7689 also immunoprecipitated a num- The intracellular localisation of HSV-1 RR was investi-
gated with the antibodies shown in Fig. 1 by immunofluo-ber of R1 degradation products. The MAbs did not immuno-
precipitate a smaller N- and C-terminally truncated polypep- rescence of infected cells fixed and permeabilised in cold
methanol. None of the antibodies reacted with proteins intide comprising R1 residues 247– 434 (data not shown). We
conclude that the residues recognised by MAbs 7689 and mock-infected BHK cells (Fig. 3A and data not shown). At
2 hr postinfection R1 was detectable in the cytoplasm of7602 are located between R1 amino acids 434– 996 and
997–1137 (C-terminus), respectively. Although both these cells (Fig. 3Bi) and remained uniformly distributed through-
out the cytoplasm at 4 (Fig. 3Bii), 6 (not shown), 8 (Fig.regions are contained within the N-terminally truncated
polypeptide comprising R1 residues 373– 1137, this poly- 3Biii), and 12 (not shown) hr postinfection. This localisation
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FIG. 5. (A) Cells infected with ts 1222 at 4 hr probed with antisera 33 (i) or 77 (ii) (140 magnification). (B) Cells after 4 hr of infection with ts 1207
probed with antisera 33 (i) or 77 (ii) (140 magnification).
of R1 was also observed after 24 hr of infection at 317 with discrete foci (Fig. 5Bi). These results show that R2
can localise to these foci without interacting with R1.(data not shown). Cells shown in Fig. 3B were probed with
antiserum 77 and a similar distribution of R1 was visualised A more detailed analysis of R1 and R2 intracellular
localisation was performed using confocal laser micros-with antiserum F1 and MAb 7689 (Figs. 3Ci and 3Cii). This
intracellular distribution of R1 was observed also with anti- copy (Fig. 6). A uniform cytoplasmic distribution of R1
was observed in cells probed with antiserum 77 at 4 hrsera F2, F3, and 106 and MAb 7602 (data not shown).
R2 was visualised with antisera 33 and 14995: it could postinfection (Figs. 6C and 6D). At this time R2 was de-
tected by antiserum 33 in discrete cytoplasmic foci closenot be detected at 2 hr postinfection (Fig. 4Ai) but by 4
hr postinfection it was found in the cytoplasm mainly to the nucleus (Figs. 6A and 6B). Similar results were
obtained with the other R1- and R2-specific antibodiesassociated with discrete foci close to the nucleus (Figs.
4Aii and 4Aiv) and maintained this localisation at 6 (Fig. (data not shown). Again, as expected protein UL42 was
detected exclusively in the nucleus (Fig. 6E).4Aiii), 8, 12, and 24 hr postinfection (data not shown).
This same distribution of R2 was also observed with Double-labelling experiments were performed with anti-
serum 33 (R2-specific) and MAb 7689 (R1-specific) (Fig.MAbs 8581 and 8578 (data not shown). As expected, at
4 hr postinfection UL42 was observed exclusively in the 7) using second antibodies conjugated respectively with
TRITC and FITC. The presence of R1 in the R2 cytoplasmicnucleus (Fig. 4B). The intracellular localisation of R1 and
R2 was the same following infection of BSC-1 cells and foci was demonstrated by yellow fluorescence in Fig. 7.
Areas of green fluorescence in the cytoplasm indicatein cells fixed with formaldehyde and permeabilised with
NP-40 (data not shown). uncomplexed R1. The amounts of R1 and R2 in wild-type
infected cells were quantitated by limiting dilution usingThe temperature-sensitive mutant ts 1222 has a defect
in the R2 gene and does not produce detectable R2 pro- Western blotting at 2, 4, 6, and 8 hr. R1 was detected at
a concentration of 0.12 mg/106 cells at 2 hr postinfectiontein (Preston et al., 1988). In cells infected with this virus
no R2 was detected (Fig. 5Ai). The intracellular localisa- and the amount of protein increased to 0.5, 1, and 2 mg/
106 cells at 4, 6, and 8 hr, respectively. R2 was barelytion of R1 was the same as that observed in wild-type
infection (Fig. 5Aii). ts 1207 expresses both R1 and R2 detectable by this method at 4 hr postinfection and con-
centrations increased to 0.18 and 0.36 mg/106 cells at 6but these do not interact at the NPT of 39.57. In cells
infected with this virus at the NPT the intracellular distri- and 8 hr, respectively. From these data, and using the
molecular masses for R1 and R2 of 136 and 38 kDa, re-bution of R1 and R2 was similar to wild-type virus infec-
tion; R1 was detected throughout the cytoplasm (Fig. 5Bii) spectively, it can be calculated that at 6 and 8 hr postinfec-
tion R1 was present in a twofold molar excess over R2.and R2 localised to the cytoplasm and was associated
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FIG. 6. Confocal microscopy images of cells at 4 hr postinfection with wild-type virus probed with (A and B) antisera 33, (C and D) antisera 77,
or (E) MAb Z1F11.
DISCUSSION degree of confidence in the conclusion than would have
been possible if only one antibody to each protein had
Our results on the intracellular localisation of HSV-1 RR been used. Our results for R1 confirm the location found
demonstrate that R1 and R2 are both found in discrete in earlier studies on transfected or infected cells (Goldstein
cytoplasmic foci which we suggest are the site of the active and Weller, 1988a,b; Wymer et al., 1989; Ali et al., 1992;
enzyme and that an excess of free R1 is distributed through- Luo and Aurelian, 1992; Smith et al., 1992, 1994; Salvucci et
out the cytoplasm. Our studies utilised several polyclonal al., 1995). Previously subcellular fractionation studies have
and monoclonal antibodies specific for a number of differ- demonstrated the cytoplasmic distribution of HSV R1 (Lan-
kinen et al., 1989; Chung et al., 1989; Smith et al., 1994).ent epitopes within R1 and R2 and so provide a higher
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FIG. 7. Double-labeling experiment with cells after 4 hr of infection with wild-type virus probed with antiserum 33 and MAb 7689 (140 magnification).
We have previously demonstrated that the N-terminal detected in cells infected with mutant ts 1222 which has
a frame-shift mutation in the R2 gene (Preston et al., 1988)protein kinase domain of HSV-1 R1 is linked to the C-
terminal reductase domain by a protease-sensitive loop and presumably expresses no stable protein product. ts
1207 expressed both R1 and R2 but these fail to interactof minimally 25 amino acids (Conner et al., 1992b; Lanki-
nen et al., 1993). Degradation of the N-terminal region at 39.57 (Frame et al., 1985; Preston et al., 1984) and
results with this virus indicate that R2 foci formation didhas been reported in vivo (Ingemarson and Lankinen,
1987; Lankinen et al., 1989) and subcellular fractionation not require interaction with R1.
The precise nature of these foci in infected cells is notstudies by Lankinen et al. (1989) suggested that the C-
terminal reductase domain partitioned almost exclusively known. The host cell RR does not form foci and both
subunits are distributed throughout the cytoplasm (En-in the nuclear fraction. It was therefore important to inves-
tigate the intracellular localisation of both the N-terminal gstrom et al., 1984; Engstrom and Rozell, 1988). Evidence
exists for complexes comprising enzymes of DNA precur-protein kinase and the C-terminal reductase domains of
R1 with antibodies specific for these regions of the pro- sor biosynthesis, including RR, which associate with
sites of DNA replication in bacteriophage T4 and vacciniatein. Here we have investigated R1 localisation with
seven antibodies which recognise different N- and C- virus (reviewed in Mathews, 1993). Such multienzyme
complexes could be advantageous by providing dNTP’sterminal epitopes. Irrespective of the antibody used R1
was detected exclusively in the cytoplasm. Indeed re- for viral DNA replication directly to replication forks. In
HSV-infected cells RR could associate with other en-sults obtained with MAb 1026, which recognises an epi-
tope within the N- and C-terminal interdomain junction zymes of DNA precursor biosynthesis in cytoplasmic foci
which may facilitate the transfer of dNTP’s to the nucleusthat is destroyed by proteolysis (Lankinen et al., 1993),
suggest that R1 remains mostly intact in tissue culture and we are investigating the localisation of other en-
zymes involved in dNTP biosynthesis.cells (data not shown). Detailed analysis by confocal mi-
croscopy failed to identify any nuclear localisation of R1. It has been suggested that the unique N-terminal do-
main of HSV-2 but not HSV-1 R1 contains a transmem-We suggest that the earlier reports of the localisation of
the reductase domain of R1 in the nuclear fraction may brane domain (Chung et al., 1990) and a small percent-
age (6 – 7%) of HSV-2 R1 associates with cell membranesbe the result of the close association of the RR complex
with the nuclear membrane or possibly the result of cyto- (Chung et al., 1989; Luo and Aurelian, 1992; Smith et
al., 1994). These authors suggested that HSV-2 R1 mayplasmic contamination.
Surprisingly, although R2 was also located exclusively function as a growth factor receptor kinase, capable of
activating transformation-related signalling pathwaysin the cytoplasm, it was mainly condensed in discrete
foci close to the nucleus. One to five of these foci per (Smith et al., 1994). Other studies with both HSV-1 and
-2 R1 have demonstrated autophosphorylation but notcell and colocalisation of R1 were detected, suggesting
that these foci contain the active enzyme. R2 was not transphosphorylation of conventional kinase substrates
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subunit is not required for ribonucleotide reductase activity. J. Gen.(Conner et al., 1992a; Cooper et al., 1995; Ali, 1995). How-
Virol. 73, 103–112.ever, a role for the R1 protein kinase during infection has
Conner, J., Furlong, J., Murray, J., Meighan, M., Cross, A., Marsden, H. S.,
yet to be established. and Clements, J. B. (1993). Herpes simplex virus type 1 ribonucleotide
Several lines of evidence point to a role for HSV R1 reductase large subunit: Regions of the protein essential for subunit
interaction and dimerisation. Biochemistry 32, 13673– 13680.additional to that of reduction of ribonucleotides. First,
Conner, J., Marsden, H. S., and Clements, J. B. (1994). Ribonucleotidethe temporal regulation of the R1 and R2 genes is differ-
reductase of herpesviruses. Rev. Med. Virol. 4, 25 – 34.ent. R1 mRNA is induced at immediate-early times postin-
Cooper, J., Conner, J., and Clements, J. B. (1995). Characterisation of
fection before transcription of R2 mRNA (Clements et al., the novel protein kinase activity present in the R1 subunit of herpes
1977). The studies reported here show that R1 protein simplex virus ribonucleotide reductase. J. Virol. 69, 4979– 4985.
de Wind, N., Berns, A., Gielkens, A., and Kimman, T. (1993). Ribonucleo-was detected at 2 hr postinfection, whereas R2 was not
tide reductase-deficient mutants of pseudorabies virus are avirulentobserved until 4 hr. Second, R1 was present in a twofold
for pigs and induce partial protective immunity. J. Gen. Virol. 74, 351–excess over R2 at 6 and 8 hr postinfection. Third, the
359.
intracellular localisation of R1 is distinct from that of R2. Dutia, B. M., Frame, M. C., Subak-Sharpe, J. H., Clark, W. N., and Mars-
Both HSV-1 and HSV-2 R1 have protein kinase activities den, H. S. (1986). Specific inhibition of herpesvirus ribonucleotide
reductase by synthetic peptides. Nature (London) 321, 431– 441.present in the unique N-terminal domain (Chung et al.,
Engstrom, Y., Rozell, B., Hansson, H. A., Stemme, S., and Thelander, L.1989; Luo and Aurelian, 1992; Conner et al., 1992a; Ali,
(1986). Localisation of ribonucleotide reductase in mammalian cells.1995; Cooper et al., 1995) and we now suggest that this
EMBO J. 3, 863–867.
free R1 could play some role important for virus replica- Engstrom, Y., and Rozell, B. (1988). Immunocytochemical evidence for
tion by phosphorylating viral and/or cellular substrates. the cytoplasmic localisation and differential expression during the
cell cycle of the M1 and M2 subunits of mammalian ribonucleotide.We speculate that the difference in cellular distribution
EMBO J. 7, 1615– 1620.is connected with a function of the PK.
Filatov, D., Ingemarson, R., Graslund, A., and Thelander, L. (1992). The
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